Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS) "REPAIRS"

Not yet recruiting

Phase 4 Results N/A

Summary of Purpose

This study is randomized, open-lable, parallel-group and comparator-controlled. 456 consecutive patients with acute ischemic stroke admitted within the first 72 hours after onset of symptoms will be studied. Those patients who will be randomly assigned to receive 2 different treatment for the first 3 days of hospitalization(non-statin-therapy group) or to immediately receive rosuvastatin orally at a dose of 20mg...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 June 2015.

1 Sep 2015 17 Jun 2015 1 Sep 2017 1 Sep 2018 1 Jun 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


  • Chun-Feng Liu, Ph.D,M.D.